Non-clinical assessment of safety, biodistribution and tumorigenicity of human mesenchymal stromal cells
Guidelines regulating the development of advanced therapy medicinal products (ATMPs) request nonclinical data for toxicity, biodistribution and tumorigenicity before mesenchymal stromal cell (MSC) products can be administered in large clinical trials. We assessed the biodistribution/persistence, saf...
Збережено в:
| Автори: | , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Elsevier
2021-01-01
|
| Серія: | Toxicology Reports |
| Предмети: | |
| Онлайн доступ: | http://www.sciencedirect.com/science/article/pii/S2214750021002006 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|